Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. - Wikidata - wikimedia - TriplyDB

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

http://www.wikidata.org/entity/Q37670299

about

Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades Rituximab use in adult primary glomerulopathy: where is the evidence?Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan.Rituximab for nephrotic syndrome in children.American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis Rituximab Treatment for Nephrotic Syndrome in Children A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood.Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome.Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment.Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease.The glomerular permeability factors in idiopathic nephrotic syndrome.Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?Biologic agents in the treatment of glomerulonephritides.Monoclonal antibodies for renal diseases: current concepts and ongoing treatments.Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome.Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.Immunology of idiopathic nephrotic syndrome.Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Treatment of membranous nephropathy: time for a paradigm shift.Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.Nephrotic syndrome in infants and children: pathophysiology and management.Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome.Low-dose ofatumumab for rituximab-resistant nephrotic syndrome.Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.Busy Bs

P2860

Q26752836-FF7D1A67-C10A-4205-BE55-7D2B32A17B6F Q28075564-2D548CEB-EC58-4E04-B030-4981FE08E931 Q30844502-49CCA8BF-92FF-4D6F-98FC-9578108F3096 Q33555088-B0E8DFB1-8359-4F42-B3D7-560DA0E3281B Q33571864-0965BE72-3BE5-445C-BC96-3B203ED932F6 Q33630988-0A449317-8D2A-4032-8D46-94879F5C416B Q34130591-5B262F71-64F2-4D80-BEFF-7B4FD7877C1A Q35040896-80DE9F49-BAA1-4507-B804-DF2E540440A9 Q35113681-60375DA7-AF6C-4725-870D-7ACA7E0EDE41 Q35674857-79873158-D8E6-4C28-9F24-B382E6D95E3E Q36003160-C594A5D2-831B-49D3-9EF0-FA2A0361AABC Q36098017-D08D218F-0BC8-499A-A6B9-F979CB7E14CA Q36104805-1212BCA6-6127-4A8B-95F7-6128589692A1 Q36151665-E9B48BF1-F216-4F09-8923-A9786913630B Q36770915-67895CAB-F535-4DD6-8FFE-22070E1ADD12 Q37261621-7B551406-08CA-41C7-AC34-C330C3ECD62B Q38449629-344422E9-9147-4EE8-BF36-BF295824D186 Q38458152-60D6CD12-DD16-4264-B3CF-AF7D39958FC0 Q38514894-44C14B94-F0CB-46CD-A625-F134D9605DFA Q38531349-BE5994A2-219A-4805-AB2C-241E2D0D6560 Q38569641-7A28CAB3-7AF0-4949-9DE3-30F3FE820CA4 Q38597096-F362781E-40A1-4FBE-816A-13289295BD1F Q38622603-7E090832-B78E-41A7-9373-43C52BB650A8 Q38679589-6F6BECE8-CB58-4E93-A422-59D6BFD5E546 Q38701126-E2512545-5CB7-457B-BBB2-584AB6F0D031 Q38815449-69410A48-0EF6-4C9F-9AB3-74975E0973CB Q38895019-1043759A-6C93-4BE9-89C2-894DB2CD2923 Q38896218-1627BE3A-91C5-4FBF-90FD-23BDD831DE07 Q39335899-E871895B-ADA2-43FF-8566-C7ED00D9B798 Q39410091-2B503536-407E-460E-874D-FB9A8CDBBCDF Q39827261-E80DF07A-B7CB-4D20-98DA-EEE9556BD16C Q40039238-823BE662-273F-4207-B6C6-301F9B4BACB4 Q40075357-D7836850-7537-4B1C-A11D-CECF1F41A0D1 Q40572300-F9E4062F-DF76-4A11-B346-82B411CA68D2 Q41022459-688A747C-40CE-4717-B8FB-5FA8DDE4E887 Q41124267-F5A116A4-EAE8-4A25-9CCD-DCAC5831F045 Q41269163-90EB04E5-C4E0-4C3B-94F7-8C32A2E05407 Q41728530-6202F50F-FD9B-45AA-B077-08608D97AEFD Q42214478-D1245921-674A-451A-9B1E-57CB1ACDEC35 Q42754554-9BF5CDD0-95AC-4646-B63A-45BD9C4851E3

P2860

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

http://www.wikidata.org/entity/Q37670299

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@en

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@nl

type

label

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@en

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@nl

prefLabel

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@en

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@nl

P1433

Q37670299-301B83CF-54AC-492D-8F1F-6F2D2B45A16B

P1476

Q37670299-61E1AD0F-0C3B-4398-9A69-C3B6C9D97992

P2093

Q37670299-256C7284-CD66-4F6D-B69A-130BB83B75A7

Q37670299-2F396592-9517-477B-801E-C32334730BE1

Q37670299-41CFDBE5-F001-4AD2-9687-C59DD3EE3E5A

Q37670299-5549FC0A-3D52-40F1-BC9C-A7195AA62DF0

Q37670299-5B39473A-7B8F-42F8-98A4-D411DC92579E

Q37670299-65EDC565-BB3B-4ED7-86C0-FDA5CCC67300

Q37670299-82D1BA95-6728-4E17-B817-473ECDF3F52F

Q37670299-A295AE27-A4CE-4771-B414-D091510059C4

Q37670299-A5E12CED-A544-464A-B909-B2C18FC91367

Q37670299-DE2D1266-D486-4C07-A40D-DA4C3B7F42C2

P2860

Q37670299-052DAE7D-642E-4FCD-9EA3-34120735875E

Q37670299-2ACF361C-CE0A-42F8-A346-4FFAE87513BB

Q37670299-2F28B716-5E2B-4641-B8A0-84FC43DECD47

Q37670299-31039D62-B140-464D-874A-F97A0F3FAE91

Q37670299-32974F4C-E4ED-432D-B8D1-CAA6062D0306

Q37670299-3B8B1054-742C-47FE-9898-2C19A8582BEA

Q37670299-3D1C4A5E-862D-48A2-8EB7-D644DA84EF60

Q37670299-4CC921F6-0D52-4438-B392-897DBFCD6371

Q37670299-5317B827-E916-4AC3-A7D7-A33B134C7C5C

Q37670299-5B5363EB-8551-42E0-B538-B488C6721A92

P304

Q37670299-6E807D30-BF2E-4330-8BB7-967E45B7D9F6

P31

Q37670299-91677A6C-AC9C-40B1-B446-FCAA1B72ED79

P356

Q37670299-53FDE1CD-9BA9-4781-87EF-ADD1E67BC868

P433

Q37670299-3AB26603-C698-4045-91E9-1FFE080DD527

P478

Q37670299-F4B74659-EE89-4C29-89B7-31A19BEE7064

P50

Q37670299-0CAB1356-902D-414D-A393-84D7947BFAA3

Q37670299-179B0654-5531-42FF-ADFB-5C35328DB065

Q37670299-17C10FCA-37B5-419F-8691-0EC1F81C1A03

Q37670299-550B90C6-2831-487D-A1C9-6233D17B0C80

Q37670299-5603A7CC-E91E-435B-A269-69E6B995B226

Q37670299-5AC3FAEC-F979-44A0-9B11-5111A7ED1DCB

P577

Q37670299-C6C28528-A076-4D01-B0BB-8ACBF8826919

P698

Q37670299-96E54F87-DC9F-4FA8-A014-5BF9E50EED57

P932

Q37670299-816663A4-6276-4C06-BD62-91C9DD0BCE8C

P356

P1433

Journal of the American Society of Nephrology

P1476

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

@en

P2093

Antonietta Chianca

http://www.w3.org/2001/XMLSchema#string

Barbara Ruggiero

http://www.w3.org/2001/XMLSchema#string

Francesco Emma

http://www.w3.org/2001/XMLSchema#string

Laura Massella

http://www.w3.org/2001/XMLSchema#string

Maddalena Marasà

http://www.w3.org/2001/XMLSchema#string

Marco Pennesi

http://www.w3.org/2001/XMLSchema#string

Marina Vivarelli

http://www.w3.org/2001/XMLSchema#string

Michael Rudnicki

http://www.w3.org/2001/XMLSchema#string

Nadia Rubis

http://www.w3.org/2001/XMLSchema#string

Paolo Cravedi

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.

Management of minimal lesion glomerulonephritis: evidence-based recommendations.

Clinical picture and outcome of primary focal segmental glomerulosclerosis.

Genetic kidney diseases.

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.

P304

850-863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013030251

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

Giovambattista Capasso

Bogdan Ene-Iordache

Rosa Maria Pollastro

Piero Ruggenenti

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24480824

http://www.w3.org/2001/XMLSchema#string

P932

3968490

http://www.w3.org/2001/XMLSchema#string